^
Association details:
Biomarker:JARID2 overexpression
Cancer:Glioma
Drug:temozolomide (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ)

Published date:
07/12/2021
Excerpt:
JARID2 overexpression significantly inhibited glioma cell viability, promoted glioma cell apoptosis upon TMZ treatment.
DOI:
10.1080/15384047.2021.1942711